Cargando…
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...
Autores principales: | Dy, Grace K., Govindan, Ramaswamy, Velcheti, Vamsidhar, Falchook, Gerald S., Italiano, Antoine, Wolf, Jürgen, Sacher, Adrian G., Takahashi, Toshiaki, Ramalingam, Suresh S., Dooms, Christophe, Kim, Dong-Wan, Addeo, Alfredo, Desai, Jayesh, Schuler, Martin, Tomasini, Pascale, Hong, David S., Lito, Piro, Tran, Qui, Jones, Simon, Anderson, Abraham, Hindoyan, Antreas, Snyder, Wendy, Skoulidis, Ferdinandos, Li, Bob T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414711/ https://www.ncbi.nlm.nih.gov/pubmed/37098232 http://dx.doi.org/10.1200/JCO.22.02524 |
Ejemplares similares
-
CodeBreaK 200: Sotorasib (AMG510) Has Broken the KRAS G12C+ NSCLC Enigma Code
por: Brazel, Danielle, et al.
Publicado: (2023) -
Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
por: Bauml, Joshua M., et al.
Publicado: (2022) -
CodeBreak 200: Sotorasib Has Not Broken the KRAS(G12C) Enigma Code
por: Zhang, Shannon S, et al.
Publicado: (2023) -
The codebreakers: the story of secret writing
por: Kahn, David
Publicado: (1967) -
Codebreakers: the inside story of Bletchley Park
por: Hinsley, F H, et al.
Publicado: (1993)